Crossmark

The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer

Crossref DOI link: https://doi.org/10.1186/s12943-018-0798-9

Published Online: 2018-02-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Poliaková, Michaela

Aebersold, Daniel M.

Zimmer, Yitzhak

Medová, Michaela https://orcid.org/0000-0003-0649-469X
Funding

Funding for this research was provided by:

Bernische Krebsliga

Stiftung zur Krebsbekämpfung

Werner und Hedy Berger-Janser Stiftung

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_156816)
More Information

Article History

Received: 15 October 2017

Accepted: 1 February 2018

First Online: 19 February 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.